Trusted Resources: Education
Scientific literature and patient education texts
Understanding Mucopolysaccharidosis Type VII (MPS VII) or Sly Syndrome
source: Ultragenyx Pharmaceutical Inc.
year: N/A
summary/abstract:MPS VII, also called Sly syndrome, is a rare, life-threatening lysosomal storage disorder, caused by mutations of the GUSB gene, which results in a deficiency of the β-glucuronidase enzyme. β-glucuronidase plays a key role in the breakdown of glycosaminoglycans (GAGs), previously called mucopolysaccharides. The inability to properly break down GAGs causes them to build up in the lysosomes.
Signs and symptoms of MPS VII generally become more severe. Hip dysplasia and worsening pulmonary function are two of the progressive symptoms commonly observed in patients with MPS VII. In some cases, people with MPS VII may develop new signs and symptoms, which may also progress. It is important to recognize the signs and symptoms of MPS VII. Early and accurate diagnosis and management may help to slow disease progression.
read more
Related Content
-
Hematopoietic Stem- and Progenitor-Cell Gene Therapy for Hurler SyndromeAllogeneic hematopoietic stem-cell trans...
-
Convergent Molecular Mechanisms Underlying Cognitive Impairment in Mucopolysaccharidosis Type IIMucopolysaccharidosis type II (MPS II) i...
-
Airway Management in Mucopolysaccharidosis: A Retrospective Case Series ReviewAirway management can be difficult in su...
-
Mass General – Lysosomal Storage Disorders ProgramThe Lysosomal Storage Disorders Program ...
-
Spinal Involvement in Morquio Ahttps://slideplayer.com/slide/3282006/...
-
Burden of Morbidity After Allogeneic Blood or Marrow Transplantation for Inborn Errors of Metabolism: A BMT Survivor...Survival after blood or marrow transplan...
-
Fetal Therapies and Trials for Lysosomal Storage Diseases: A Survey of Attitudes of Parents and PatientsLysosomal storage diseases (LSDs) are in...